Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 18OTHER 17NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma 108Central Nervous System Neoplasms 42Osteosarcoma 38Gliosarcoma 34Glioblastoma 34Rhabdomyosarcoma 27Lymphoma 22Fibrosarcoma 22Liposarcoma 21Leiomyosarcoma 20Neuroblastoma 19Hemangiosarcoma 19Astrocytoma 19Sarcoma, Synovial 18Neuroectodermal Tumors, Primitive, Peripheral 18Dendritic Cell Sarcoma, Interdigitating 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Neurofibrosarcoma 17Histiocytoma, Malignant Fibrous 17Brain Neoplasms 17Sarcoma, Kaposi 16Malignant mesenchymal tumor 16Burkitt Lymphoma 16Ovarian Neoplasms 15Recurrence 14Leukemia 14Sarcoma, Alveolar Soft Part 12Oligodendroglioma 12AIDS-related Kaposi sarcoma 12Hemangiopericytoma, Malignant 11

Interventions

Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Skin Neoplasms × Sarcoma × Clear all
NCT04498767 2024-08-26

OligoRARE

European Organisation for Research and Treatment of Cancer - EORTC

Phase NA Recruiting
200 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡